Last Updated: July 1, 2026

FLAVOXATE Drug Patent Profile

Name: FLAVOXATE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Flavoxate, and what generic alternatives are available?

Flavoxate is a drug marketed by Epic Pharma, Impax Pharms, and Padagis Us. and is included in three NDAs.

The generic ingredient in FLAVOXATE is flavoxate hydrochloride. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the flavoxate hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Flavoxate

A generic version of FLAVOXATE was approved as flavoxate hydrochloride by PADAGIS US on December 16^th, 2004.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for FLAVOXATE?
What are the global sales for FLAVOXATE?
What is Average Wholesale Price for FLAVOXATE?

Summary for FLAVOXATE

US Patents:	0
Applicants:	3
NDAs:	3
Drug Prices:	Drug price information for FLAVOXATE
DailyMed Link:	FLAVOXATE at DailyMed

Drug patent expirations by year for FLAVOXATE

US Patents and Regulatory Information for FLAVOXATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Epic Pharma	FLAVOXATE HYDROCHLORIDE	flavoxate hydrochloride	TABLET;ORAL	076835-001	Nov 30, 2005	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Impax Pharms	FLAVOXATE HYDROCHLORIDE	flavoxate hydrochloride	TABLET;ORAL	076234-001	Aug 28, 2003		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Padagis Us	FLAVOXATE HYDROCHLORIDE	flavoxate hydrochloride	TABLET;ORAL	076831-001	Dec 16, 2004	AB	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.